Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

Clinical trial NCT05443971 · TERMINATED

Trial details

NCT number: NCT05443971
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Non-Small Cell Carcinoma Stage III Lung Cancer AJCC v8

Start date: 2024-01-08
Primary completion: 2025-06-28
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.